View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Gastrointestinal Cancer News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 25, 2023
2 min read
Save

Increased cancer burden in older adults with type 2 diabetes over past 20 years

Increased cancer burden in older adults with type 2 diabetes over past 20 years

Cancer burden among older adults with type 2 diabetes has increased in the past 2 decades while all-cause mortality rates at all ages have decreased, according to a 20-year population-based study published in Diabetologia.

SPONSORED CONTENT
January 24, 2023
3 min read
Save

Stereotactic body radiation extends survival in hepatocellular carcinoma

Stereotactic body radiation extends survival in hepatocellular carcinoma

Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among patients with hepatocellular carcinoma, according to study results presented at ASCO Gastrointestinal Cancers Symposium.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
January 24, 2023
2 min read
Save

Use of antibiotics safe during durvalumab-based treatment for biliary tract cancer

Use of antibiotics safe during durvalumab-based treatment for biliary tract cancer

Patients with advanced biliary tract cancer can safely use antibiotics while benefiting from treatment with durvalumab plus gemcitabine and cisplatin, according to study results presented at ASCO Gastrointestinal Cancers Symposium.

SPONSORED CONTENT
January 24, 2023
2 min read
Save

Long-course chemoradiation may improve organ preservation rates in rectal cancer

Long-course chemoradiation may improve organ preservation rates in rectal cancer

A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal cancer, according to a study presented at ASCO Gastrointestinal Cancers Symposium.

SPONSORED CONTENT
January 23, 2023
3 min read
Save

Trifluridine/tipiracil plus bevacizumab prolongs survival in refractory colorectal cancer

Trifluridine/tipiracil plus bevacizumab prolongs survival in refractory colorectal cancer

The addition of bevacizumab to trifluridine/tipiracil demonstrated a statistically significant and clinically meaningful improvement in OS vs. trifluridine/tipiracil alone among adults with refractory metastatic colorectal cancer.

SPONSORED CONTENT
January 23, 2023
3 min read
Save

Follow-up colonoscopy rates after positive colorectal cancer screening result are low

Follow-up colonoscopy rates after positive colorectal cancer screening result are low

Many patients who received a positive stool-based screening test result for colorectal cancer did not receive a follow-up colonoscopy within 1 year, according to the results of a mixed-methods cohort study.

SPONSORED CONTENT
January 23, 2023
2 min read
Save

Tislelizumab regimen new first-line option for gastric, gastroesophageal cancer subgroup

Tislelizumab regimen new first-line option for gastric, gastroesophageal cancer subgroup

Tislelizumab plus chemotherapy demonstrated statistically significant and clinically meaningful improvements in OS vs. chemotherapy alone among patients with PD-L1-positive, advanced gastric or gastroesophageal junction adenocarcinoma.

SPONSORED CONTENT
January 21, 2023
1 min read
Save

The Wistar Institute names cancer center deputy director

The Wistar Institute names cancer center deputy director

Maureen E. Murphy, PhD, has been appointed deputy director of Ellen and Ronald Caplan Cancer Center at The Wistar Institute.

SPONSORED CONTENT
January 20, 2023
3 min read
Save

Zolbetuximab benefits subset of patients with gastric, gastroesophageal junction cancer

Zolbetuximab benefits subset of patients with gastric, gastroesophageal junction cancer

First-line treatment with zolbetuximab added to chemotherapy significantly extended OS and PFS among adults with certain forms of claudin-18.2-positive/HER2-negative gastric adenocarcinoma, results of the phase 3 SPOTLIGHT trial showed.

SPONSORED CONTENT
January 20, 2023
8 min read
Save

Mark Lewis, MD, discusses career motivation, Twitter and oncology’s emotional ‘yin-yang’

Mark Lewis, MD, discusses career motivation, Twitter and oncology’s emotional ‘yin-yang’

Mark A. Lewis, MD, has two special drawers in his office desk — one with notes of appreciation he has received from patients over the years and the other with his patients’ obituaries.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails